Revision: Nov. 29, 2023, 11:24 a.m.
2024 SESSION
24-2946.1
05/08
SENATE BILL [bill number]
AN ACT relative to insurance coverage for blood testing associated with elevated lead levels.
SPONSORS: [sponsors]
COMMITTEE: [committee]
─────────────────────────────────────────────────────────────────
ANALYSIS
This bill expands mandatory health insurance coverage for blood tests associated with elevated lead levels.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
24-2946.1
05/08
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
AN ACT relative to insurance coverage for blood testing associated with elevated lead levels.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 Short Title. This act shall be known as the lead poisoning prevention and treatment act of 2024.
2 Accident and Health Insurance. Amend RSA 415:6-v to read as follows:
415:6-v Coverage for Blood Lead Testing. Each insurer that issues or renews any individual policy, plan, or contract of accident or health insurance providing benefits for medical or hospital expenses shall provide to persons covered by such insurance who are residents of this state coverage for [the costs of blood lead testing conducted pursuant to RSA 130-A:5-a. Benefits provided under this section shall not be subject to any greater co-payment, deductible, or coinsurance than any other similar benefits provided by the insurer.] any and all costs associated with blood lead testing conducted pursuant to RSA 130-A:5-a, including any and all costs associated with necessary follow-up testing should an elevated blood lead at or above the level that warrants notification pursuant to RSA 130-A:6 be discovered.
3 Accident and Health Insurance. Amend RSA 415:18-aa to read as follows:
415:18-aa Coverage for Blood Lead Testing. Each insurer that issues or renews any policy of group or blanket accident or health insurance providing benefits for medical or hospital expenses shall provide to each group, or to the portion of each group comprised of certificate holders of such insurance who are residents of this state, coverage for [the costs of blood lead testing conducted pursuant to RSA 130-A:5-a. Benefits provided under this section shall not be subject to any greater co-payment, deductible, or coinsurance than any other similar benefits provided by the insurer.] any and all costs associated with blood lead testing conducted pursuant to RSA 130-A:5-a, including any and all costs associated with necessary follow-up testing should an elevated blood lead at or above the level that warrants notification pursuant to RSA 130-A:6 be discovered.
4 Effective Date. This act shall take effect 60 days after its passage.